TheProfitWatch

CVKD - Cadrenal Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.92 0.14 (1.04%) --- --- --- --- 0.14 (1.04%) --- ---

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.87
Diluted EPS:
-1.87
Basic P/E:
-7.5214
Diluted P/E:
-7.5214
RSI(14) 1m:
100.0
VWAP:
14.06
RVol:
0.3626

Events

Period Kind Movement Occurred At
1m Price decrease 1m 14.15 -0.15 (-1.05%) Oct 15 09:57
1m Price decrease 1m 14.06 -0.29 (-2.0%) Oct 15 09:31

Related News